CD4 and infection: The above results were in line with the viral copy results showing that mouse immunization induced neutralizing antibodies and CD4+ cellular response against Omicron BA.1 and protected H11-K18-hACE-2 mice against infection, with a reduction in viral load and pathological changes, and subcutaneous injections may provide better protection.